Sunday, July 25, 2021 8:17:59 PM
https://choprafoundation.org/category/articles/page/36/
Recent MYMD News
- TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today • Business Wire • 07/24/2024 01:05:00 PM
- MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc. • Business Wire • 07/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 01:04:23 PM
- MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer • Business Wire • 06/17/2024 01:00:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/31/2024 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 01:10:03 PM
- MyMD Pharmaceuticals Secures Strategic Investments • Business Wire • 05/21/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:01:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 04:00:19 PM
- MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing • Business Wire • 03/05/2024 02:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:13:35 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:27:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:57:03 PM
- MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing • Business Wire • 02/13/2024 04:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:15:12 PM
- MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis • Business Wire • 12/06/2023 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 01:00:10 PM
- MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain • Business Wire • 10/19/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:30:23 PM
- MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 • Business Wire • 10/04/2023 11:30:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM